フローサイトメトリー市場は、2021年の43億ドルから、2026年には63億ドルに達し、CAGRは8.1％と予想されます。フローサイトメトリー市場の成長を促す主な要因としては、世界的なHIV / AIDSおよび癌の発生率と罹患率の上昇、研究＆学術におけるフローサイトメトリー技術の採用の拡大、免疫学と免疫オンコロジー研究の分野における官民による取組みの強化、技術の進歩、フローサイトメトリーワークフローへのAIプラットフォームの組み込みの増加とおよびフローサイトメトリーソフトウェアの進歩が挙げられます。
ウイルスの蔓延を抑えることに成功したと考えていた国々にとって、COVID-19パンデミックの第2波が発生し、ウイルスに対するワクチンの世界的な需要が高まり、混乱を招いています。
サーモフィッシャーサイエンティフィック社（米国）の科学者へのインタビューによると 、カリフォルニア大学は、SARS-CoV-2の影響を研究することに関する大規模なプロジェクトのために、研究者、看護師、および臨床医からのボランティアを求めました。科学者は、精製タンパク質を使用し、Attune NxTフローサイトメーターなどの追加のフローサイトメトリーアナライザーを使用してフローサイトメトリー用の抗体パネルを作成し、血液サンプルを分析しました。
したがって、免疫系がSARS-CoV-2にどのように反応するかを調査するため、いくつかのCOVID-19調査研究でフローサイトメトリー技術が使用されていることから、COVID-19パンデミックはこの市場にプラスの影響を与えました。
目次
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 36)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 FLOW CYTOMETRY MARKET SEGMENTATION
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY USED FOR THE STUDY
1.5 STAKEHOLDERS
1.6 LIMITATIONS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 41)
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
FIGURE 2 FLOW CYTOMETRY MARKET: BREAKDOWN OF PRIMARIES
2.2 MARKET ESTIMATION METHODOLOGY
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
2.2.1.1 Key industry insights
FIGURE 3 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS, 2020
FIGURE 4 AVERAGE MARKET SIZE ESTIMATION, 2020
2.2.2 USAGE-BASED MARKET ESTIMATION
FIGURE 5 MARKET SIZE ESTIMATION: FLOW CYTOMETRY MARKET
2.3 GROWTH RATE ASSUMPTIONS/GROWTH FORECAST
FIGURE 6 FLOW CYTOMETRY MARKET: CAGR PROJECTIONS, 2021-2026
FIGURE 7 FLOW CYTOMETRY MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
2.4 DATA TRIANGULATION METHODOLOGY
FIGURE 9 FLOW CYTOMETRY MARKET: DATA TRIANGULATION
2.5 RESEARCH ASSUMPTIONS
2.6 RISK ANALYSIS
3 EXECUTIVE SUMMARY (Page No. - 53)
FIGURE 10 FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2021 VS. 2026 (USD MILLION)
FIGURE 11 FLOW CYTOMETRY MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
FIGURE 12 FLOW CYTOMETRY MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
FIGURE 13 FLOW CYTOMETRY MARKET, BY REGION, 2021 VS. 2026 (USD MILLION)
4 PREMIUM INSIGHTS (Page No. - 57)
4.1 FLOW CYTOMETRY MARKET OVERVIEW
FIGURE 14 TECHNOLOGICAL ADVANCEMENTS IN FLOW CYTOMETRY PRODUCTS TO SUPPORT MARKET GROWTH
4.2 NORTH AMERICA: FLOW CYTOMETRY MARKET SHARE, BY TECHNOLOGY AND COUNTRY (2020)
FIGURE 15 CELL-BASED FLOW CYTOMETRY ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN FLOW CYTOMETRY MARKET IN 2020
4.3 FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 16 CANCER DIAGNOSTIC APPLICATIONS WILL CONTINUE TO DOMINATE THE FLOW CYTOMETRY MARKET IN 2026
4.4 FLOW CYTOMETRY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 17 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH IN THE FLOW CYTOMETRY MARKET FROM 2021 TO 2026
5 MARKET OVERVIEW (Page No. - 61)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 18 FLOW CYTOMETRY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Rising global incidence and prevalence of HIV/AIDS and cancer
TABLE 1 INCIDENCE OF HIV/AIDS, BY REGION, 2020
TABLE 2 GLOBAL CANCER INCIDENCE, 2020 VS. 2040
5.2.1.2 Growing adoption of flow cytometry techniques in research and academia
5.2.1.3 Growing public-private initiatives in immunology and immuno-oncology research
5.2.1.4 Technological advancements
TABLE 3 IMPORTANT TECHNOLOGICAL ADVANCEMENTS IN THE FLOW CYTOMETRY MARKET DURING 2018-2021
5.2.1.5 Increasing incorporation of AI platforms in flow cytometry workflow and advancements in flow cytometry software
TABLE 4 IMPORTANT SOFTWARE-RELATED ADVANCEMENTS IN THE FLOW CYTOMETRY MARKET DURING 2018-2021
5.2.2 RESTRAINTS
5.2.2.1 Significant product costs
5.2.3 OPPORTUNITIES
5.2.3.1 Growing market presence in the Asia Pacific region
5.2.3.2 Evolving pipeline for stem cell research
TABLE 5 NIH-ESTIMATED STEM CELL RESEARCH EXPENDITURE DATA
5.2.3.3 Adoption of recombinant DNA technology for antibody production
5.2.3.4 Evolution of tandem flow cytometry technologies
5.2.4 CHALLENGES
5.2.4.1 Complexities related to reagent development
5.2.4.2 Dearth of well-trained and skilled professionals
5.3 IMPACT OF COVID-19 ON THE FLOW CYTOMETRY MARKET
5.4 REGULATORY ASSESSMENT
5.4.1 STRINGENT FDA REQUIREMENTS
5.4.2 STRINGENT ANALYTE-SPECIFIC REAGENT RULE
5.4.3 LACK OF WELL-DEFINED VALIDATION PROTOCOLS FOR CELL-BASED ASSAYS
5.4.4 ABSENCE OF ESTABLISHED LABORATORY-DEVELOPED TEST GUIDELINES ON CELL-BASED FLUORESCENCE ASSAYS
5.4.5 GREATER GLOBAL RECOGNITION FOR IVD CE MARK APPROVALS
5.4.6 US REIMBURSEMENT SCENARIO
5.5 PATENT ANALYSIS
5.5.1 NUMBER OF PUBLICATIONS OVER THE LAST 10 YEARS
5.5.2 TOP PATENT OWNERS IN THE LAST 20 YEARS
5.5.3 TOP 10 PLAYERS WITH THE HIGHEST NUMBER OF PATENT APPLICATIONS
5.5.4 LIST OF RECENT PATENTS
5.6 SUPPLY CHAIN ANALYSIS
FIGURE 19 DIRECT DISTRIBUTION STRATEGY PREFERRED BY PROMINENT COMPANIES
5.6.1 KEY INFLUENCERS
5.7 VALUE CHAIN ANALYSIS
FIGURE 20 FLOW CYTOMETRY MARKET: VALUE CHAIN ANALYSIS
5.8 ECOSYSTEM ANALYSIS OF THE FLOW CYTOMETRY MARKET
FIGURE 21 ECOSYSTEM ANALYSIS OF THE FLOW CYTOMETRY MARKET
5.8.1 ROLE IN THE ECOSYSTEM
5.9 PORTER’S FIVE FORCES ANALYSIS
TABLE 6 FLOW CYTOMETRY MARKET: PORTER’S FIVE FORCES ANALYSIS
5.9.1 COMPETITIVE RIVALRY AMONG EXISTING PLAYERS
5.9.2 BARGAINING POWER OF SUPPLIERS
5.9.3 BARGAINING POWER OF BUYERS
5.9.4 THREAT OF SUBSTITUTES
5.9.5 THREAT OF NEW ENTRANTS
5.10 TRENDS AND DISRUPTIONS IMPACTING CUSTOMERS
FIGURE 22 TRENDS AND DISRUPTIONS IN THE FLOW CYTOMETRY MARKET
5.11 RANGES/SCENARIOS
FIGURE 23 DEPENDING ON HOW THE UNCERTAINTIES UNFOLD, WE SEE A SPECTRUM OF SCENARIOS FOR THE FLOW CYTOMETRY MARKET - 2020
5.12 TRADE DATA
TABLE 7 IMPORT DATA FOR FLOW CYTOMETERS, BY COUNTRY, 2016-2020 (USD THOUSAND)
TABLE 8 EXPORT DATA FOR FLOW CYTOMETERS, BY COUNTRY, 2016-2020 (USD THOUSAND)
6 FLOW CYTOMETRY MARKET, BY TECHNOLOGY (Page No. - 83)
6.1 INTRODUCTION
TABLE 9 FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
6.2 CELL-BASED FLOW CYTOMETRY
6.2.1 RESEARCH & DEVELOPMENT ON NOVEL THERAPEUTIC AGENTS WILL DRIVE THE GROWTH OF THE CELL-BASED FLOW CYTOMETRY MARKET
TABLE 10 CELL-BASED FLOW CYTOMETRY MARKET, BY REGION, 2019-2026 (USD MILLION)
6.3 BEAD-BASED FLOW CYTOMETRY
6.3.1 PROCEDURAL ADVANTAGES OF BEAD-BASED FLOW CYTOMETRY HAVE DRIVEN MARKET GROWTH
TABLE 11 BEAD-BASED FLOW CYTOMETRY MARKET, BY REGION, 2019-2026 (USD MILLION)
7 FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE (Page No. - 87)
7.1 INTRODUCTION
TABLE 12 FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
7.2 REAGENTS & CONSUMABLES
7.2.1 CONTINUOUS REQUIREMENT OF FLOW CYTOMETRY REAGENTS BY END USERS TO DRIVE MARKET GROWTH
TABLE 13 FLOW CYTOMETRY REAGENTS & CONSUMABLES MARKET, BY REGION, 2019-2026 (USD MILLION)
TABLE 14 FLOW CYTOMETRY REAGENTS & CONSUMABLES MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 15 FLOW CYTOMETRY REAGENTS & CONSUMABLES MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
TABLE 16 FLOW CYTOMETRY REAGENTS & CONSUMABLES MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
TABLE 17 FLOW CYTOMETRY REAGENTS & CONSUMABLES MARKET, BY END USER, 2019-2026 (USD MILLION)
7.3 INSTRUMENTS
TABLE 18 FLOW CYTOMETRY INSTRUMENTS MARKET, BY REGION, 2019-2026 (USD MILLION)
TABLE 19 FLOW CYTOMETRY INSTRUMENTS MARKET, BY REGION, 2019-2026 (UNITS)
TABLE 20 FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 21 FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (UNITS)
TABLE 22 FLOW CYTOMETRY INSTRUMENTS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 23 FLOW CYTOMETRY INSTRUMENTS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
TABLE 24 FLOW CYTOMETRY INSTRUMENTS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
TABLE 25 FLOW CYTOMETRY INSTRUMENTS MARKET, BY END USER, 2019-2026 (USD MILLION)
7.3.1 CELL ANALYZERS
TABLE 26 FLOW CYTOMETRY-BASED CELL ANALYZERS MARKET, BY REGION, 2019-2026 (USD MILLION)
TABLE 27 FLOW CYTOMETRY-BASED CELL ANALYZERS MARKET, BY REGION, 2019-2026 (UNITS)
TABLE 28 FLOW CYTOMETRY-BASED CELL ANALYZERS MARKET, BY PRICE RANGE, 2019-2026 (USD MILLION)
TABLE 29 FLOW CYTOMETRY-BASED CELL ANALYZERS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 30 FLOW CYTOMETRY-BASED CELL ANALYZERS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
TABLE 31 FLOW CYTOMETRY-BASED CELL ANALYZERS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
TABLE 32 FLOW CYTOMETRY-BASED CELL ANALYZERS MARKET, BY END USER, 2019-2026 (USD MILLION)
7.3.1.1 High-range cell analyzers
7.3.1.1.1 Wide adoption of high-range cell analyzers among end users owing to their advantages to drive market growth
TABLE 33 HIGH-RANGE CELL ANALYZERS MARKET, BY REGION, 2019-2026 (USD MILLION)
7.3.1.2 Mid-range cell analyzers
7.3.1.2.1 Wide availability of compact and high-performance analyzers to support market growth
TABLE 34 MID-RANGE CELL ANALYZERS MARKET, BY REGION, 2019-2026 (USD MILLION)
7.3.1.3 Low-range cell analyzers
7.3.1.3.1 Low-range analyzers find significant adoption among price-sensitive end users
TABLE 35 LOW-RANGE CELL ANALYZERS MARKET, BY REGION, 2019-2026 (USD MILLION)
7.3.2 CELL SORTERS
TABLE 36 FLOW CYTOMETRY-BASED CELL SORTERS MARKET, BY REGION, 2019-2026 (USD MILLION)
TABLE 37 FLOW CYTOMETRY-BASED CELL SORTERS MARKET, BY REGION, 2019-2026 (USD UNITS)
TABLE 38 FLOW CYTOMETRY-BASED CELL SORTERS MARKET, BY PRICE RANGE, 2019-2026 (USD MILLION)
TABLE 39 FLOW CYTOMETRY-BASED CELL SORTERS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 40 FLOW CYTOMETRY-BASED CELL SORTERS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
TABLE 41 FLOW CYTOMETRY-BASED CELL SORTERS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
TABLE 42 FLOW CYTOMETRY-BASED CELL SORTERS MARKET, BY END USER, 2019-2026 (USD MILLION)
7.3.2.1 High-range cell sorters
7.3.2.1.1 High cost and budgetary limitations among end users to restrain market growth to a certain extent
TABLE 43 HIGH-RANGE CELL SORTERS MARKET, BY REGION, 2019-2026 (USD MILLION)
7.3.2.2 Mid-range cell sorters
7.3.2.2.1 Product launches and the cost-efficiency of mid-range sorters have enabled the growth of this market segment
TABLE 44 MID-RANGE CELL SORTERS MARKET, BY REGION, 2019-2026 (USD MILLION)
7.3.2.3 Low-range cell sorters
7.3.2.3.1 Small-scale labs and research facilities are the major end user of low-range sorters
TABLE 45 LOW-RANGE CELL SORTERS MARKET, BY REGION, 2019-2026 (USD MILLION)
7.4 SERVICES
7.4.1 REMOTE SERVICES ENSURE WORKFLOW CONTINUITY AND MAXIMIZE PERFORMANCE
TABLE 46 FLOW CYTOMETRY SERVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
TABLE 47 FLOW CYTOMETRY SERVICES MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 48 FLOW CYTOMETRY SERVICES MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
TABLE 49 FLOW CYTOMETRY SERVICES MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
TABLE 50 FLOW CYTOMETRY SERVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
7.5 SOFTWARE
7.5.1 AVAILABILITY OF A WIDE RANGE OF ANALYSIS SOFTWARE AND ADVANCEMENTS TO DRIVE MARKET GROWTH
TABLE 51 FLOW CYTOMETRY SOFTWARE MARKET, BY REGION, 2019-2026 (USD MILLION)
TABLE 52 FLOW CYTOMETRY SOFTWARE MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 53 FLOW CYTOMETRY SOFTWARE MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
TABLE 54 FLOW CYTOMETRY SOFTWARE MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
TABLE 55 FLOW CYTOMETRY SOFTWARE MARKET, BY END USER, 2019-2026 (USD MILLION)
7.6 ACCESSORIES
7.6.1 PROCEDURAL BENEFITS OFFERED BY ACCESSORIES AND AVAILABILITY OF ADVANCED FLOW CYTOMETRY ACCESSORIES ARE THE MAJOR FACTORS SUPPORTING MARKET GROWTH
TABLE 56 FLOW CYTOMETRY ACCESSORIES MARKET, BY REGION, 2019-2026 (USD MILLION)
TABLE 57 FLOW CYTOMETRY ACCESSORIES MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 58 FLOW CYTOMETRY ACCESSORIES MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
TABLE 59 FLOW CYTOMETRY ACCESSORIES MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
TABLE 60 FLOW CYTOMETRY ACCESSORIES MARKET, BY END USER, 2019-2026 (USD MILLION)
8 FLOW CYTOMETRY MARKET, BY APPLICATION (Page No. - 115)
8.1 INTRODUCTION
TABLE 61 FLOW CYTOMETRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
8.2 RESEARCH APPLICATIONS
TABLE 62 FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
TABLE 63 FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
8.2.1 PHARMACEUTICAL & BIOTECHNOLOGY
TABLE 64 FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
8.2.1.1 Drug discovery
8.2.1.1.1 Growing use of phenotypic cell-based assays in drug discovery to support market growth
TABLE 65 FLOW CYTOMETRY MARKET FOR DRUG DISCOVERY, BY REGION, 2019-2026 (USD MILLION)
8.2.1.2 Stem cell research
8.2.1.2.1 Increasing investments in stem cell research to boost the adoption of flow cytometry instruments
TABLE 66 FLOW CYTOMETRY MARKET FOR STEM CELL RESEARCH, BY REGION, 2019-2026 (USD MILLION)
8.2.1.3 In vitro toxicity testing
8.2.1.3.1 Need to reduce the time and cost of drug development processes to drive market growth
TABLE 67 FLOW CYTOMETRY MARKET FOR IN VITRO TOXICITY TESTING, BY REGION, 2019-2026 (USD MILLION)
8.2.2 IMMUNOLOGY
8.2.2.1 Increasing prevalence of infectious and autoimmune diseases to drive the demand for flow cytometry by research laboratories
TABLE 68 FLOW CYTOMETRY MARKET FOR IMMUNOLOGY APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
8.2.3 CELL SORTING
8.2.3.1 Development of technologically advanced cell sorters to boost the market growth
TABLE 69 FLOW CYTOMETRY MARKET FOR CELL SORTING APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
8.2.4 APOPTOSIS
8.2.4.1 Flow cytometry techniques are used to identify changes occurring during apoptosis
TABLE 70 FLOW CYTOMETRY MARKET FOR APOPTOSIS APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
8.2.5 CELL CYCLE ANALYSIS
8.2.5.1 Chromosomal abnormalities can be detected using flow cytometry
TABLE 71 FLOW CYTOMETRY MARKET FOR CELL CYCLE ANALYSIS APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
8.2.6 CELL VIABILITY
8.2.6.1 Cell viability is a key parameter studied using flow cytometry
TABLE 72 FLOW CYTOMETRY MARKET FOR CELL VIABILITY APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
8.2.7 CELL COUNTING
8.2.7.1 Flow cytometry enables easy differentiation of cells via scattering or staining
TABLE 73 FLOW CYTOMETRY MARKET FOR CELL COUNTING APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
8.2.8 OTHER RESEARCH APPLICATIONS
TABLE 74 FLOW CYTOMETRY MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
8.3 CLINICAL APPLICATIONS
TABLE 75 FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
TABLE 76 FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
8.3.1 CANCER DIAGNOSTICS
8.3.1.1 Flow cytometry tools are used to determine the malignancy of a tumor
TABLE 77 FLOW CYTOMETRY MARKET FOR CANCER APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
8.3.2 HEMATOLOGY
8.3.2.1 Flow cytometry identifies a wide range of cell surfaces and cytoplasmic antigens
TABLE 78 FLOW CYTOMETRY MARKET FOR HEMATOLOGY APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
8.3.3 AUTOIMMUNE DISEASES
8.3.3.1 Flow cytometry helps in the diagnosis of primary immunodeficiencies
TABLE 79 FLOW CYTOMETRY MARKET FOR IMMUNODEFICIENCY DISEASE APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
8.3.4 ORGAN &TISSUE TRANSPLANTATION
8.3.4.1 The use of flow cytometry to reduce organ rejection rates has contributed to market growth
TABLE 80 FLOW CYTOMETRY MARKET FOR ORGAN TRANSPLANTATION APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
8.3.5 OTHER CLINICAL APPLICATIONS
TABLE 81 FLOW CYTOMETRY MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
8.4 INDUSTRIAL APPLICATIONS
8.4.1 A WIDE END-USER BASE WILL DRIVE MARKET GROWTH
TABLE 82 FLOW CYTOMETRY MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
9 FLOW CYTOMETRY MARKET, BY END USER (Page No. - 133)
9.1 INTRODUCTION
TABLE 83 FLOW CYTOMETRY MARKET, BY END USER, 2019-2026 (USD MILLION)
9.2 ACADEMIC & RESEARCH INSTITUTES
9.2.1 GROWING NUMBER OF RESEARCH PROJECTS THROUGH INDUSTRY-ACADEMIA COLLABORATIONS TO DRIVE MARKET GROWTH
TABLE 84 FLOW CYTOMETRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2019-2026 (USD MILLION)
9.3 HOSPITALS & CLINICAL TESTING LABORATORIES
9.3.1 RISING AWARENESS AND DISEASE PREVALENCE HAVE SUSTAINED THE DEMAND FOR FLOW CYTOMETERS IN HOSPITALS & CLINICAL TESTING LABS
TABLE 85 FLOW CYTOMETRY MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY REGION, 2019-2026 (USD MILLION)
9.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
9.4.1 INCREASE IN DRUG DISCOVERY ACTIVITIES TO DRIVE MARKET GROWTH
TABLE 86 FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2019-2026 (USD MILLION)
10 FLOW CYTOMETRY MARKET, BY REGION (Page No. - 138)
10.1 INTRODUCTION
TABLE 87 FLOW CYTOMETRY MARKET, BY REGION, 2019-2026 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 24 NORTH AMERICA: FLOW CYTOMETRY MARKET SNAPSHOT
TABLE 88 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 89 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
TABLE 90 NORTH AMERICA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 91 NORTH AMERICA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (UNITS)
TABLE 92 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
TABLE 93 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 94 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY END USER, 2019-2026 (USD MILLION)
10.2.1 US
10.2.1.1 High prevalence of cancer, HIV-AIDS, and autoimmune disorders in the US to drive market growth
TABLE 95 US: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
TABLE 96 US: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 97 US: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
TABLE 98 US: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 99 US: FLOW CYTOMETRY MARKET, BY END USER, 2019-2026 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Ongoing government initiatives to support life science research will boost the demand for flow cytometry products in Canada
TABLE 100 CANADA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
TABLE 101 CANADA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 102 CANADA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
TABLE 103 CANADA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 104 CANADA: FLOW CYTOMETRY MARKET, BY END USER, 2019-2026 (USD MILLION)
10.3 EUROPE
TABLE 105 EUROPE: FLOW CYTOMETRY MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 106 EUROPE: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
TABLE 107 EUROPE: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 108 EUROPE: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (UNITS)
TABLE 109 EUROPE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
TABLE 110 EUROPE: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 111 EUROPE: FLOW CYTOMETRY MARKET, BY END USER, 2019-2026 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Strong R&D infrastructure, training, and awareness programs ensure market growth in Germany
TABLE 112 GERMANY: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
TABLE 113 GERMANY: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 114 GERMANY: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
TABLE 115 GERMANY: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 116 GERMANY: FLOW CYTOMETRY MARKET, BY END USER, 2019-2026 (USD MILLION)
10.3.2 UK
10.3.2.1 Growing acceptance of flow cytometry products for clinical diagnostics in the UK to drive market growth
TABLE 117 UK: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
TABLE 118 UK: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 119 UK: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
TABLE 120 UK: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 121 UK: FLOW CYTOMETRY MARKET, BY END USER, 2019-2026 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 Increasing R&D spending and strong government funding for proteomics and genomics research to fuel the adoption of flow cytometry
TABLE 122 FRANCE: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
TABLE 123 FRANCE: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 124 FRANCE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
TABLE 125 FRANCE: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 126 FRANCE: FLOW CYTOMETRY MARKET, BY END USER, 2019-2026 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Increasing geriatric population and growing life science research activities to drive market demand in Italy
TABLE 127 ITALY: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
TABLE 128 ITALY: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 129 ITALY: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
TABLE 130 ITALY: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 131 ITALY: FLOW CYTOMETRY MARKET, BY END USER, 2019-2026 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Growing focus on cancer diagnosis is increasing the use of flow cytometry products in Spain
TABLE 132 SPAIN: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
TABLE 133 SPAIN: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 134 SPAIN: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
TABLE 135 SPAIN: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 136 SPAIN: FLOW CYTOMETRY MARKET, BY END USER, 2019-2026 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 137 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
TABLE 138 REST OF EUROPE: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 139 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
TABLE 140 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 141 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY END USER, 2019-2026 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 25 ASIA PACIFIC: FLOW CYTOMETRY MARKET SNAPSHOT
TABLE 142 APAC: FLOW CYTOMETRY MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 143 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
TABLE 144 ASIA PACIFIC: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 145 ASIA PACIFIC: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (UNITS)
TABLE 146 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
TABLE 147 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 148 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY END USER, 2019-2026 (USD MILLION)
10.4.1 JAPAN
10.4.1.1 Growing flow cytometry-based research activities to drive market growth in Japan
TABLE 149 JAPAN: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
TABLE 150 JAPAN: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 151 JAPAN: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
TABLE 152 JAPAN: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 153 JAPAN: FLOW CYTOMETRY MARKET, BY END USER, 2019-2026 (USD MILLION)
10.4.2 CHINA
10.4.2.1 High incidence of target diseases and growing presence of global players to drive market growth in China
TABLE 154 CHINA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
TABLE 155 CHINA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 156 CHINA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
TABLE 157 CHINA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 158 CHINA: FLOW CYTOMETRY MARKET, BY END USER, 2019-2026 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Increasing pharma R&D and strong government funding in the biotechnology industry to drive market growth in India
TABLE 159 INDIA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
TABLE 160 INDIA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 161 INDIA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
TABLE 162 INDIA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 163 INDIA: FLOW CYTOMETRY MARKET, BY END USER, 2019-2026 (USD MILLION)
10.4.4 AUSTRALIA
10.4.4.1 Rising cancer prevalence and increasing government initiatives to drive market growth in Australia
TABLE 164 AUSTRALIA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
TABLE 165 AUSTRALIA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 166 AUSTRALIA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
TABLE 167 AUSTRALIA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 168 AUSTRALIA: FLOW CYTOMETRY MARKET, BY END USER, 2019-2026 (USD MILLION)
10.4.5 SOUTH KOREA
10.4.5.1 Strong government support for the biotechnology industry and rising awareness of flow cytometry to drive the South Korean market
TABLE 169 SOUTH KOREA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
TABLE 170 SOUTH KOREA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 171 SOUTH KOREA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
TABLE 172 SOUTH KOREA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 173 SOUTH KOREA: FLOW CYTOMETRY MARKET, BY END USER, 2019-2026 (USD MILLION)
10.4.6 REST OF ASIA PACIFIC
TABLE 174 ROAPAC: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
TABLE 175 ROAPAC: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 176 ROAPAC: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
TABLE 177 ROAPAC: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 178 ROAPAC: FLOW CYTOMETRY MARKET, BY END USER, 2019-2026 (USD MILLION)
10.5 LATIN AMERICA
TABLE 179 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 180 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
TABLE 181 LATIN AMERICA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 182 LATIN AMERICA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (UNITS)
TABLE 183 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
TABLE 184 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 185 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY END USER, 2019-2026 (USD MILLION)
10.5.1 BRAZIL
10.5.1.1 Brazil dominates the Latin American flow cytometry market
TABLE 186 BRAZIL: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
TABLE 187 BRAZIL: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 188 BRAZIL: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
TABLE 189 BRAZIL: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 190 BRAZIL: FLOW CYTOMETRY MARKET, BY END USER, 2019-2026 (USD MILLION)
10.5.2 MEXICO
10.5.2.1 Favorable trade agreements to support imports and accessibility to flow cytometry products in Mexico
TABLE 191 MEXICO: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
TABLE 192 MEXICO: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 193 MEXICO: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
TABLE 194 MEXICO: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 195 MEXICO: FLOW CYTOMETRY MARKET, BY END USER, 2019-2026 (USD MILLION)
10.5.3 REST OF LATIN AMERICA
TABLE 196 ROLA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
TABLE 197 ROLA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 198 ROLA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
TABLE 199 ROLA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 200 ROLA: FLOW CYTOMETRY MARKET, BY END USER, 2019-2026 (USD MILLION)
10.6 MIDDLE EAST & AFRICA
10.6.1 FUNDING INITIATIVES AND STRATEGIC PARTNERSHIPS IN THE RESEARCH SECTOR TO DRIVE MARKET GROWTH
TABLE 201 MIDDLE EAST & AFRICA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
TABLE 202 MIDDLE EAST & AFRICA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 203 MIDDLE EAST & AFRICA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (UNITS)
TABLE 204 MIDDLE EAST & AFRICA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
TABLE 205 MIDDLE EAST & AFRICA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 206 MIDDLE EAST & AFRICA: FLOW CYTOMETRY MARKET, BY END USER, 2019-2026 (USD MILLION)
11 COMPETITIVE LANDSCAPE (Page No. - 198)
11.1 INTRODUCTION
11.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS
FIGURE 26 FLOW CYTOMETRY MARKET: STRATEGIES ADOPTED
11.3 MARKET SHARE ANALYSIS
FIGURE 27 FLOW CYTOMETRY MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020
TABLE 207 FLOW CYTOMETRY MARKET: DEGREE OF COMPETITION
11.4 COMPANY EVALUATION QUADRANT
11.4.1 STARS
11.4.2 EMERGING LEADERS
11.4.3 PERVASIVE PLAYERS
11.4.4 PARTICIPANTS
FIGURE 28 FLOW CYTOMETRY MARKET: COMPETITIVE LEADERSHIP MAPPING, 2020
11.5 COMPETITIVE LEADERSHIP MAPPING: EMERGING COMPANIES/SMES/START-UPS (2020)
11.5.1 PROGRESSIVE COMPANIES
11.5.2 STARTING BLOCKS
11.5.3 RESPONSIVE COMPANIES
11.5.4 DYNAMIC COMPANIES
FIGURE 29 FLOW CYTOMETRY MARKET: COMPETITIVE LEADERSHIP MAPPING FOR SMES/START-UPS, 2020
11.6 COMPETITIVE BENCHMARKING
11.6.1 COMPANY FOOTPRINT
TABLE 208 COMPANY PRODUCT FOOTPRINT
TABLE 209 COMPANY REGIONAL FOOTPRINT
11.7 COMPETITIVE SCENARIO AND TRENDS
11.7.1 PRODUCT LAUNCHES
TABLE 210 FLOW CYTOMETRY MARKET: PRODUCT LAUNCHES, JANUARY 2018-JULY 2021
11.7.2 DEALS
TABLE 211 FLOW CYTOMETRY MARKET: DEALS, JANUARY 2018-JULY 2021
12 COMPANY PROFILES (Page No. - 211)
12.1 KEY COMPANIES
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 BECTON, DICKINSON AND COMPANY
TABLE 212 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
FIGURE 30 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2020)
TABLE 213 BECTON, DICKINSON AND COMPANY: PRODUCT/SERVICE OFFERINGS
TABLE 214 BECTON, DICKINSON AND COMPANY: PRODUCT LAUNCHES, APPROVALS, AND ENHANCEMENTS
12.1.2 DANAHER CORPORATION
TABLE 215 DANAHER CORPORATION: BUSINESS OVERVIEW
FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2020)
TABLE 216 DANAHER CORPORATION: PRODUCT/SERVICE OFFERINGS
TABLE 217 DANAHER CORPORATION: PRODUCT LAUNCHES AND ENHANCEMENTS
TABLE 218 DANAHER CORPORATION: DEALS
12.1.3 THERMO FISHER SCIENTIFIC, INC.
TABLE 219 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW
FIGURE 32 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2020)
TABLE 220 THERMO FISHER SCIENTIFIC, INC.: PRODUCT/SERVICE OFFERINGS
TABLE 221 THERMO FISHER SCIENTIFIC, INC.: PRODUCT LAUNCHES AND ENHANCEMENTS
TABLE 222 THERMO FISHER SCIENTIFIC, INC.: DEALS
12.1.4 AGILENT TECHNOLOGIES, INC.
TABLE 223 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW
FIGURE 33 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2020)
TABLE 224 AGILENT TECHNOLOGIES, INC.: PRODUCT OFFERINGS
TABLE 225 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES
TABLE 226 AGILENT TECHNOLOGIES, INC.: DEALS
12.1.5 SONY BIOTECHNOLOGY INC. (A SUBSIDIARY OF SONY GROUP CORPORATION)
TABLE 227 SONY GROUP CORPORATION: BUSINESS OVERVIEW
FIGURE 34 SONY GROUP CORPORATION: COMPANY SNAPSHOT (2020)
TABLE 228 SONY BIOTECHNOLOGY INC.: PRODUCT/SERVICE OFFERINGS
12.1.6 BIO-RAD LABORATORIES, INC.
TABLE 229 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
FIGURE 35 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2020)
TABLE 230 BIO-RAD LABORATORIES, INC.: PRODUCT/SERVICE OFFERINGS
TABLE 231 BIO-RAD LABORATORIES, INC.: DEALS
12.1.7 MILTENYI BIOTEC
TABLE 232 MILTENYI BIOTEC: BUSINESS OVERVIEW
TABLE 233 MILTENYI BIOTEC: PRODUCT/SERVICE OFFERINGS
TABLE 234 MILTENYI BIOTEC: PRODUCT LAUNCHES
12.1.8 ENZO BIOCHEM, INC.
TABLE 235 ENZO BIOCHEM, INC.: BUSINESS OVERVIEW
FIGURE 36 ENZO BIOCHEM, INC.: COMPANY SNAPSHOT (2020)
TABLE 236 ENZO BIOCHEM, INC.: PRODUCT OFFERINGS
12.1.9 SYSMEX CORPORATION
TABLE 237 SYSMEX CORPORATION: BUSINESS OVERVIEW
FIGURE 37 SYSMEX CORPORATION: COMPANY SNAPSHOT (2020)
TABLE 238 SYSMEX CORPORATION: PRODUCT/SERVICE OFFERINGS
TABLE 239 SYSMEX CORPORATION: PRODUCT LAUNCHES
12.1.10 BIOMÉRIEUX SA
TABLE 240 BIOMÉRIEUX SA: BUSINESS OVERVIEW
FIGURE 38 BIOMÉRIEUX SA: COMPANY SNAPSHOT (2020)
TABLE 241 BIOMÉRIEUX SA: PRODUCT/SERVICE OFFERINGS
12.1.11 CYTONOME/ST, LLC.
TABLE 242 CYTONOME/ST, LLC: BUSINESS OVERVIEW
TABLE 243 CYTONOME/ST, LLC: PRODUCT OFFERINGS
12.1.12 SARTORIUS AG
TABLE 244 SARTORIUS AG: BUSINESS OVERVIEW
FIGURE 39 SARTORIUS AG: COMPANY SNAPSHOT (2020)
TABLE 245 SARTORIUS AG: PRODUCT OFFERINGS
TABLE 246 SARTORIUS AG: PRODUCT LAUNCHES/UPGRADES
12.1.13 CYTEK BIOSCIENCES
TABLE 247 CYTEK BIOSCIENCES: BUSINESS OVERVIEW
TABLE 248 CYTEK BIOSCIENCES: PRODUCT/SERVICE OFFERINGS
TABLE 249 CYTEK BIOSCIENCES: PRODUCT LAUNCHES/APPROVALS
TABLE 250 CYTEK BIOSCIENCES: DEALS
TABLE 251 CYTEK BIOSCIENCES: OTHER DEVELOPMENTS
12.1.14 UNION BIOMETRICA, INC.
TABLE 252 UNION BIOMETRICA, INC.: BUSINESS OVERVIEW
TABLE 253 UNION BIOMETRICA, INC.: PRODUCT/SERVICE OFFERINGS
12.1.15 LUMINEX CORPORATION
TABLE 254 LUMINEX CORPORATION: BUSINESS OVERVIEW
FIGURE 40 LUMINEX CORPORATION: COMPANY SNAPSHOT (2020)
TABLE 255 LUMINEX CORPORATION: PRODUCT/SERVICE OFFERINGS
TABLE 256 LUMINEX CORPORATION: DEALS
12.2 START-UP PLAYERS
12.2.1 APOGEE FLOW SYSTEMS LTD.
TABLE 257 APOGEE FLOW SYSTEMS LTD.: BUSINESS OVERVIEW
TABLE 258 APOGEE FLOW SYSTEMS LTD.: PRODUCT/SERVICE OFFERINGS
TABLE 259 APOGEE FLOW SYSTEMS LTD.: PRODUCT LAUNCHES/UPGRADES
12.2.2 STRATEDIGM, INC.
TABLE 260 STRATEDIGM, INC.: BUSINESS OVERVIEW
TABLE 261 STRATEDIGM, INC.: PRODUCT/SERVICE OFFERINGS
TABLE 262 STRATEDIGM, INC.: PRODUCT LAUNCHES/UPGRADES
TABLE 263 STRATEDIGM, INC.: DEALS
12.2.3 NANOCELLECT BIOMEDICAL, INC.
12.2.4 ON-CHIP BIOTECHNOLOGIES CO., LTD.
12.2.5 NEXCELOM BIOSCIENCE LLC.
12.2.6 BENNUBIO INC.
12.2.7 ORFLO TECHNOLOGIES
12.2.8 BAY BIOSCIENCE CO., LTD.
12.2.9 CYTOBUOY B.V.
12.2.10 BIOLEGEND, INC.
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX (Page No. - 274)
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
